https://clinicaltrials.gov/ct2/show/NCT03417245?type=Intr&cond=hemophilia&lupd_s=05%2F01%2F2019&lupd_d=14
Conditions : Hemophilia A; Hemophilia B
Interventions : Drug: fitusiran; Drug: factor VIII or factor IX
Sponsor : Genzyme, a Sanofi Company
Recruiting
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
NCT03417245
Wed, 31 Jan 2018 12:00:00 EST
Last Update Posted: 05/15/19 07:45AM
